Weight-loss medications could alleviate migraine pain and reducing asthma symptoms, according to new research. Experts have noted that individuals using these drugs reported a decrease in asthma flare-ups and a reduced reliance on inhalers. Separately, a study has drawn a connection between the drug Wegovy and a decline in prescriptions for migraine medication among women taking it for weight management. These findings, unveiled at the European Congress On Obesity in Turkey, contribute to a growing body of evidence suggesting that glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs may offer advantages beyond their primary use for weight loss . In England, these medications are already prescribed to mitigate the risk of heart attacks and strokes. The latest research further strengthens the understanding of these drugs' potential therapeutic scope. Experts examined Danish health registries between 2022 and 2024, including data on 150,000 people who started Wegovy .…